Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Fajac

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Elife|April 14, 2025
Oncogenic and teratogenic effects of <i>Trp53</i><sup>Y217C</sup>, an inflammation-prone mouse model of the human hotspot mutant <i>TP53</i><sup>Y220C</sup>Sara Jaber, Eliana Eldawra, Jeanne Rakotopare, et al.
Breast Cancer Research and Treatment|May 14, 2013
Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patientsPierre Lévy, Joseph Gligorov, Martine Antoine, et al.
Genetic Testing and Molecular Biomarkers|September 23, 2010
A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysisFlorence Coulet, Filipe Pires, Etienne Rouleau, et al.
BMC Medicine|March 31, 2007
In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot studyIsabelle Sermet-Gaudelus, Michel Renouil, Anne Fajac, et al.
Elife|September 19, 2024
Mutant mice lacking alternatively spliced p53 isoforms unveil <i>Ackr4</i> as a male-specific prognostic factor in Myc-driven B-cell lymphomasAnne Fajac, Iva Simeonova, Julia Leemput, et al.
Molecular & Cellular Proteomics : MCP|July 15, 2005
Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patientsNoura Bensalem, Ana Paula Ventura, Benoît Vallée, et al.
Scientific Reports|June 10, 2022
Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patientsGuillaume Voiriot, Karim Dorgham, Guillaume Bachelot, et al.
Chest|June 8, 2021
Pulmonary Alveolar Proteinosis After Allogeneic Hematopoietic Stem-Cell Transplantation in Adults: A French Société Francophone de Greffe de Moelle et Thérapie Cellulaire SurveyHelene Salvator, Colas Tcherakian, Natacha Maillard, et al.
Cancers|April 14, 2025
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair GenesMaximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
Breast Cancer Research : BCR|August 4, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutationMaximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Elife|April 14, 2025
Oncogenic and teratogenic effects of <i>Trp53</i><sup>Y217C</sup>, an inflammation-prone mouse model of the human hotspot mutant <i>TP53</i><sup>Y220C</sup>Sara Jaber, Eliana Eldawra, Jeanne Rakotopare, et al.
Breast Cancer Research and Treatment|May 14, 2013
Influence of ABCB1 polymorphisms and docetaxel pharmacokinetics on pathological response to neoadjuvant chemotherapy in breast cancer patientsPierre Lévy, Joseph Gligorov, Martine Antoine, et al.
Genetic Testing and Molecular Biomarkers|September 23, 2010
A one-step prescreening for point mutations and large rearrangement in BRCA1 and BRCA2 genes using quantitative polymerase chain reaction and high-resolution melting curve analysisFlorence Coulet, Filipe Pires, Etienne Rouleau, et al.
BMC Medicine|March 31, 2007
In vitro prediction of stop-codon suppression by intravenous gentamicin in patients with cystic fibrosis: a pilot studyIsabelle Sermet-Gaudelus, Michel Renouil, Anne Fajac, et al.
Elife|September 19, 2024
Mutant mice lacking alternatively spliced p53 isoforms unveil <i>Ackr4</i> as a male-specific prognostic factor in Myc-driven B-cell lymphomasAnne Fajac, Iva Simeonova, Julia Leemput, et al.
Molecular & Cellular Proteomics : MCP|July 15, 2005
Down-regulation of the anti-inflammatory protein annexin A1 in cystic fibrosis knock-out mice and patientsNoura Bensalem, Ana Paula Ventura, Benoît Vallée, et al.
Scientific Reports|June 10, 2022
Identification of bronchoalveolar and blood immune-inflammatory biomarker signature associated with poor 28-day outcome in critically ill COVID-19 patientsGuillaume Voiriot, Karim Dorgham, Guillaume Bachelot, et al.
Chest|June 8, 2021
Pulmonary Alveolar Proteinosis After Allogeneic Hematopoietic Stem-Cell Transplantation in Adults: A French Société Francophone de Greffe de Moelle et Thérapie Cellulaire SurveyHelene Salvator, Colas Tcherakian, Natacha Maillard, et al.
Cancers|April 14, 2025
Screening Mammography and Breast Cancer: Variation in Risk with Rare Deleterious or Predicted Deleterious Variants in DNA Repair GenesMaximiliano Ribeiro-Guerra, Marie-Gabrielle Dondon, Séverine Eon-Marchais, et al.
Breast Cancer Research : BCR|August 4, 2021
Diagnostic chest X-rays and breast cancer risk among women with a hereditary predisposition to breast cancer unexplained by a BRCA1 or BRCA2 mutationMaximiliano Ribeiro Guerra, Juliette Coignard, Séverine Eon-Marchais, et al.
Pageof 4